A Double-Blind, Randomized, Placebo-Controlled Study of the Efficacy and Safety of Weekly Procrit Given to Gastric or Rectal Patients
Conditions
- Gastrointestinal Cancer
- Rectal Cancer
Interventions
- DRUG: Procrit (epoetin alfa)
Sponsor
M.D. Anderson Cancer Center
Collaborators